Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease

Percutaneous coronary intervention (PCI) is one of the most common procedures performed in medicine. However, its net benefit among patients with chronic kidney disease (CKD) is less well established than in the general population. The prevalence of patients suffering from both CAD and CKD is high,...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine 2022-04, Vol.11 (9), p.2380
Main Authors: Caracciolo, Alessandro, Scalise, Renato Francesco Maria, Ceresa, Fabrizio, Bagnato, Gianluca, Versace, Antonio Giovanni, Licordari, Roberto, Perfetti, Silvia, Lofrumento, Francesca, Irrera, Natasha, Santoro, Domenico, Patanè, Francesco, Di Bella, Gianluca, Costa, Francesco, Micari, Antonio
Format: Article
Language:English
Subjects:
Angina pectoris
Angioplasty
Cardiovascular disease
Clinical medicine
Clinical trials
Disease prevention
Drug dosages
Heart attacks
Heart failure
Hydration
Ischemia
Kidney diseases
Patients
Review
Urine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Percutaneous coronary intervention (PCI) is one of the most common procedures performed in medicine. However, its net benefit among patients with chronic kidney disease (CKD) is less well established than in the general population. The prevalence of patients suffering from both CAD and CKD is high, and is likely to increase in the coming years. Planning the adequate management of this group of patients is crucial to improve their outcome after PCI. This starts with proper preparation before the procedure, the use of all available means to reduce contrast during the procedure, and the implementation of modern strategies such as radial access and drug-eluting stents. At the end of the procedure, personalized antithrombotic therapy for the patient's specific characteristics is advisable to account for the elevated ischemic and bleeding risk of these patients.
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm11092380